Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer
Plasma TCTP is a prognostic biomarker, reflecting clinically relevant immunosuppressive myeloid signals in patients with gastric cancer.
Authors
- Gwanghee Lee (ORCID: https://orcid.org/0000-0001-9580-1959)
- Hideyuki Yanai (ORCID: https://orcid.org/0000-0002-0115-9000)
- Hyungsu Jeon (ORCID: https://orcid.org/0000-0002-6474-4506)
- Jeong‐Hyun Ryou (ORCID: https://orcid.org/0009-0005-4812-9983)
- Yeong Hak Bang (ORCID: https://orcid.org/0000-0001-6544-6431)
- Seyoung Jung (ORCID: https://orcid.org/0000-0002-0285-5972)
- Jaewon Hyung (ORCID: https://orcid.org/0000-0002-0680-4486)
- Jeong Seok Lee (ORCID: https://orcid.org/0000-0001-8261-7044)
- Hyung Eun Lee
- Hyung‐Don Kim (ORCID: https://orcid.org/0000-0001-9959-0642)
- Min‐Hee Ryu (ORCID: https://orcid.org/0000-0002-1033-1263)
- Changhoon Yoo (ORCID: https://orcid.org/0000-0002-1451-8455)
- Won Tae Kim (ORCID: https://orcid.org/0000-0002-9359-3073)
- Jiae Kim (ORCID: https://orcid.org/0009-0000-5609-1165)
- Hayoung Lee (ORCID: https://orcid.org/0009-0004-5346-8894)
- Mi-Ra Yoon (ORCID: https://orcid.org/0009-0001-0803-3259)
- Hee Jeong Kim
Institutions
- Ulsan College (KR)
- Korea Advanced Institute of Science and Technology (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- The University of Tokyo (JP)
Publication Details
- Journal
- Journal for ImmunoTherapy of Cancer
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/jitc-2024-010455
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Korea Technology and Information Promotion Agency for SMEs